tegafur gimeracil oteracil potassium leucovorin calcium oral formulation

Drug Overview

The medication known as tegafur gimeracil oteracil potassium leucovorin calcium oral formulation (often referred to in clinical research by its code name, TAS-118) is a highly advanced, multi-part medicine used in cancer care. It is a powerful example of a Targeted Therapy and a “Smart Drug.” Instead of being a single chemical, it is a carefully balanced team of four different ingredients packed into an easy-to-take oral capsule.

This combination is designed to attack cancer cells aggressively while actively protecting the rest of your body from severe side effects. It takes traditional chemotherapy and upgrades it, allowing patients to take their treatment at home rather than spending hours attached to an IV drip in a hospital.

Here are the key details about this medication:

• Generic Name: Tegafur-gimeracil-oteracil potassium-leucovorin calcium oral formulation.
• US Brand Names: Currently under development (Investigational). It is known in major global clinical trials as TAS-118. (A similar version without leucovorin is known globally as Teysuno or S-1).
• Drug Class: Antineoplastic Combination / Fluoropyrimidine Antagonist / Thymidylate Synthase Inhibitor.
• Route of Administration: Oral (taken by mouth as a capsule).
• FDA Approval Status: This specific 4-drug combination is currently investigational in the United States and is being studied in advanced phase III clinical trials. It is not yet fully FDA-approved for standard public use, though its individual components are widely used globally.

What Is It and How Does It Work? (Mechanism of Action)

To understand this medicine, it helps to look at how its four distinct ingredients work together as a team at the molecular level. It acts as a “Smart Drug” because it controls exactly where and how the cancer-killing chemicals are released in the body.

Here is how the four parts work:

1. Tegafur (The Trojan Horse): Tegafur is what doctors call a “prodrug.” On its own, it does not harm cells. Once you swallow it, it travels through your blood and is slowly turned into an active cancer-killing drug called 5-fluorouracil (5-FU). 5-FU acts like a fake building block. When cancer cells try to use it to build their DNA and RNA, the cell’s machinery breaks down, and the cancer cell dies.
2. Gimeracil (The Shield): Normally, your liver breaks down 5-FU very quickly using an enzyme called DPD. Gimeracil temporarily blocks this DPD enzyme. This acts as a shield, keeping the cancer-killing 5-FU in your bloodstream much longer so it can fight the tumor effectively.
3. Oteracil Potassium (The Gut Guard): 5-FU can cause terrible stomach and bowel issues. Oteracil is a special chemical that stays mostly in your digestive tract. It blocks an enzyme (OPRT) in your gut, preventing the drug from attacking your healthy stomach and intestine cells. This greatly reduces nausea and diarrhea.
4. Leucovorin Calcium (The Enhancer): This is a form of folic acid. Inside the cancer cell, leucovorin acts as a powerful booster. It helps the active 5-FU lock tightly onto a crucial cancer enzyme called Thymidylate Synthase (TYMS). This creates an unbreakable “chemical lock” (a ternary complex) that completely shuts down the cancer cell’s ability to divide and grow.

FDA-Approved Clinical Indications

Because this specific four-part oral formulation is currently an investigational agent in the US, it does not yet have official FDA-approved indications for routine daily practice. However, it is being extensively tested and used in approved clinical trials worldwide for the following:

• Oncological Uses (In Clinical Trials):
  • Advanced Gastric (Stomach) Cancer: Used as a primary treatment to shrink tumors and extend life.
  • Colorectal Cancer: Used to stop the spread of cancer in the colon and rectum.
  • Solid Tumors: Explored in cases where tumors have spread (metastasized) and require strong, whole-body treatment.
• Non-oncological Uses:
  • None. This medication is strictly for treating cancer.

Dosage and Administration Protocols

Because this is a powerful cancer medication, it must be taken exactly as prescribed by an oncologist. It is taken by mouth, which offers a much better quality of life compared to hospital IV infusions.

Dose Adjustments

• Kidney (Renal) Insufficiency: Your kidneys help clear this drug from your body. If you have mild to moderate kidney problems (a Creatinine Clearance under 50 ml/min), your doctor will lower your daily dose to keep you safe.
• Liver (Hepatic) Insufficiency: Dose changes are handled on a case-by-case basis if severe liver disease is present.

Clinical Efficacy and Research Results

Recent clinical studies (between 2020 and 2025) show very promising results for this combination therapy. Medical trials are proving that this oral medicine is just as effective, and sometimes better, than older, harder-to-take treatments.

• Advanced Stomach Cancer (The SOLAR Trial): In a major global Phase 3 clinical trial involving hundreds of patients, doctors compared this new drug (TAS-118) combined with oxaliplatin against older standard treatments. The results showed that patients taking the new oral combination lived longer. The median overall survival rate was 16.0 months, compared to 15.1 months for the older treatment group. This proved that the drug provides a clear, life-extending benefit.
• Colorectal Cancer Success: Recent case reports and ongoing studies from 2023 show that when this oral combination is paired with other new targeted therapies (like fruquintinib), patients experience a longer “progression-free survival.” This means the medicine successfully stops the cancer from growing or spreading for a significantly longer period of time.

Safety Profile and Side Effects

While the “Smart Drug” design of this medicine helps protect your healthy cells, it is still a strong chemotherapy and can cause side effects.

WARNING: DPD Enzyme Deficiency > Although not yet carrying a formal US FDA Black Box Warning under this exact name, all drugs containing tegafur/5-FU carry a strict medical warning. Patients who naturally lack the DPD enzyme in their liver cannot break this drug down. In these rare cases, taking this drug can lead to severe, life-threatening toxicity. Your doctor may test you for this before you start.

Common Side Effects (>10%)

• Anemia: Low red blood cells, which can make you feel pale, weak, and tired.
• Neutropenia: Low white blood cells, which makes it harder for your body to fight off everyday infections.
• Fatigue: Feeling heavily drained or tired, requiring extra rest.
• Digestive Issues: Mild to moderate diarrhea, nausea, and a decreased appetite.

Serious Adverse Events

• Febrile Neutropenia: A dangerous drop in white blood cells accompanied by a high fever. This is a medical emergency.
• Severe Dehydration: Caused by extreme diarrhea or vomiting, which can hurt your kidneys.

Management Strategies

• If your white blood cells drop too low, your doctor may pause your treatment or give you a growth-factor injection to boost your immune system.
• If you experience diarrhea, your medical team will provide anti-diarrhea medications and ask you to drink special hydration fluids.

Research Areas

While there is currently no direct, established link between this specific drug and stem cell regenerative therapies, it is a massive focus in the world of Immunotherapy and modern cancer research.

Scientists are currently testing how well this drug works when given alongside immune checkpoint inhibitors (medicines that take the brakes off your body’s immune system so it can hunt cancer). Because the “Gut Guard” (oteracil) protects the patient’s stomach, patients stay healthier during treatment. A healthier patient has a stronger immune system, which scientists believe makes advanced Immunotherapies work much better.

Patient Management and Practical Recommendations

To keep you safe and ensure the medicine works its best, your healthcare team will monitor you closely.

Pre-treatment Tests to be Performed

• Blood Tests: Complete Blood Count (CBC) to check your red and white blood cells.
• Kidney and Liver Panels: To ensure your organs can safely process the medicine.
• Pregnancy Test: A test is required for women of childbearing age. This medicine can severely harm an unborn baby.
• DPD Deficiency Testing: A genetic or blood test to ensure your body can safely handle the drug.

Precautions During Treatment

• Infection Risk: Because your white blood cells may drop, avoid large crowds and people who are visibly sick.
• Sun Sensitivity: This medicine can make your skin burn easily. Wear sunscreen and protective clothing.

“Do’s and Don’ts” List

• DO drink plenty of water (at least 8 to 10 glasses a day) to protect your kidneys.
• DO wash your hands frequently to prevent catching colds or infections.
• DO swallow the capsules whole.
• DON’T chew, break, or open the capsules.
• DON’T take any new vitamins, herbal supplements, or over-the-counter medicines without asking your cancer doctor first.
• DON’T ignore a fever. If your temperature reaches 100.4°F (38°C) or higher, call your doctor immediately

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only and does not constitute medical advice. This specific oral combination formulation (tegafur, gimeracil, oteracil potassium, and leucovorin calcium) is an investigational agent in the US and is available primarily through clinical trials or specific regional approvals. Always consult with a qualified healthcare professional or your treating oncologist regarding diagnosis, treatment options, potential side effects, and your eligibility for clinical trials.